News
Cardinal Health Shares Sink on Mixed 4Q Results, $1.9 Billion Solaris Health Deal -- Update
Looking forward, Cardinal Health now expects adjusted earnings of $9.30 to $9.50 a share in its fiscal 2026, up from a prior outlook of $9.10 to $9.30 a share. Analysts were looking for adjusted earnings of $9.26 a share.
Cardinal Health builds out urology focus with $1.9B deal for Solaris Health
Cardinal Health acquired Solaris Health as it continues to build out its multispecialty management services organization platform. | Cardinal Health MSO platforms will reach about 3,000 providers in 32 states once the Solaris Health deal closes,
23h
Cardinal Health's $1.9 Billion Urology Bet Sends Shares Sliding -- But Could Spark Long-Term Growth
Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...
Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...
U.S. equities were up at midday, with the Nasdaq and S&P 500 trading at record highs, as consumer inflation rose less than ...
Cardinal Health dropped its share prices by 7.21 percent on Tuesday to finish at $146.3 apiece as investors soured on its ...
Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization ...
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback